View the 2021 Event Guide to See What You Missed!
Join industry leaders at the only dedicated forum for innovating the future of non-small cell lung cancer drug development.
- Explore the current top players and their competition coming up through the pipelines: the novel targeted and immune therapies as mono therapies and in combination studies
- Investigate the mutation profiles and mechanisms of resistance to devise rational therapeutic strategy
- Glimpse the horizon of next-generation developments in therapies and precision oncology in the push to early disease and addressing the patient population response differences to address this global unmet need
Download the event guide to discover:
- 35+ industry-leading speakers
- 25+ cutting-edge, technical presentations
- A deep-dive workshop designed to maximize your drug development
- 3 expert panel sessions to ask your burning questions